The role of the serotonergic system in REM sleep behavior disorder

Dario Arnaldi, Francesco Famà, Fabrizio De Carli, Silvia Morbelli, Michela Ferrara, Agnese Picco, Jennifer Accardo, Alberto Primavera, Gianmario Sambuceti, Flavio Nobili

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Study Objectives: REM sleep behavior disorder (RBD) can be induced by antidepressants, especially serotonin reuptake inhibitors (SSRI), thus a role of the serotonergic system in the pathogenesis of RBD has been proposed. However, the serotonergic system integrity in idiopathic RBD (iRBD) is still unknown. We aimed to study brain stem serotonergic system integrity, by means of 123I-FP-CIT-SPECT, in a group of iRBD patients as compared to normal subjects. Design: Single-center, prospective observational study. Setting: University hospital. Patients or Participants: Twenty iRBD outpatients and 23 age-matched normal controls. Measurements and Results: The diagnosis of RBD was determined clinically and confirmed by means of overnight, laboratory-based videopolysomnography. Both iRBD patients and normal subjects underwent 123I-FP-CIT-SPECT as a marker of dopamine transporter (DAT) at basal ganglia level and of serotonin transporter (SERT) at brainstem and thalamus levels. 123I-FP-CIT-SPECT images were analyzed and compared between iRBD patients and controls by means of both region of interest analysis at basal ganglia, midbrain, pons and thalamus levels, and voxel-based analysis, taking into account age and the use of SSRI as confounding factors. No difference in 123I-FP-CIT-SPECT specific to nondisplaceable binding ratios (SBR) values was found between iRBD and normal subjects at brainstem and thalamus levels while iRBD patients showed lower SBR values in all basal ganglia nuclei (P <0.0001) compared to controls. Conclusions: These results suggest that the serotonergic system is not directly involved in RBD pathogenesis while confirming nigro-striatal dopaminergic deafferentation in iRBD.

Original languageEnglish
Pages (from-to)1505-1509
Number of pages5
JournalSleep
Volume38
Issue number9
DOIs
Publication statusPublished - Sep 1 2015

Fingerprint

REM Sleep Behavior Disorder
Basal Ganglia
Single-Photon Emission-Computed Tomography
Thalamus
Brain Stem
Corpus Striatum
Serotonin Plasma Membrane Transport Proteins
Dopamine Plasma Membrane Transport Proteins
Pons
Serotonin Uptake Inhibitors
Mesencephalon
Antidepressive Agents
Observational Studies
Outpatients
Prospective Studies
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

Keywords

  • RBD
  • Serotonin
  • SPECT

ASJC Scopus subject areas

  • Physiology (medical)
  • Clinical Neurology

Cite this

Arnaldi, D., Famà, F., De Carli, F., Morbelli, S., Ferrara, M., Picco, A., ... Nobili, F. (2015). The role of the serotonergic system in REM sleep behavior disorder. Sleep, 38(9), 1505-1509. https://doi.org/10.5665/sleep.5000

The role of the serotonergic system in REM sleep behavior disorder. / Arnaldi, Dario; Famà, Francesco; De Carli, Fabrizio; Morbelli, Silvia; Ferrara, Michela; Picco, Agnese; Accardo, Jennifer; Primavera, Alberto; Sambuceti, Gianmario; Nobili, Flavio.

In: Sleep, Vol. 38, No. 9, 01.09.2015, p. 1505-1509.

Research output: Contribution to journalArticle

Arnaldi, D, Famà, F, De Carli, F, Morbelli, S, Ferrara, M, Picco, A, Accardo, J, Primavera, A, Sambuceti, G & Nobili, F 2015, 'The role of the serotonergic system in REM sleep behavior disorder', Sleep, vol. 38, no. 9, pp. 1505-1509. https://doi.org/10.5665/sleep.5000
Arnaldi D, Famà F, De Carli F, Morbelli S, Ferrara M, Picco A et al. The role of the serotonergic system in REM sleep behavior disorder. Sleep. 2015 Sep 1;38(9):1505-1509. https://doi.org/10.5665/sleep.5000
Arnaldi, Dario ; Famà, Francesco ; De Carli, Fabrizio ; Morbelli, Silvia ; Ferrara, Michela ; Picco, Agnese ; Accardo, Jennifer ; Primavera, Alberto ; Sambuceti, Gianmario ; Nobili, Flavio. / The role of the serotonergic system in REM sleep behavior disorder. In: Sleep. 2015 ; Vol. 38, No. 9. pp. 1505-1509.
@article{f9c1ae075879490395395474ef279795,
title = "The role of the serotonergic system in REM sleep behavior disorder",
abstract = "Study Objectives: REM sleep behavior disorder (RBD) can be induced by antidepressants, especially serotonin reuptake inhibitors (SSRI), thus a role of the serotonergic system in the pathogenesis of RBD has been proposed. However, the serotonergic system integrity in idiopathic RBD (iRBD) is still unknown. We aimed to study brain stem serotonergic system integrity, by means of 123I-FP-CIT-SPECT, in a group of iRBD patients as compared to normal subjects. Design: Single-center, prospective observational study. Setting: University hospital. Patients or Participants: Twenty iRBD outpatients and 23 age-matched normal controls. Measurements and Results: The diagnosis of RBD was determined clinically and confirmed by means of overnight, laboratory-based videopolysomnography. Both iRBD patients and normal subjects underwent 123I-FP-CIT-SPECT as a marker of dopamine transporter (DAT) at basal ganglia level and of serotonin transporter (SERT) at brainstem and thalamus levels. 123I-FP-CIT-SPECT images were analyzed and compared between iRBD patients and controls by means of both region of interest analysis at basal ganglia, midbrain, pons and thalamus levels, and voxel-based analysis, taking into account age and the use of SSRI as confounding factors. No difference in 123I-FP-CIT-SPECT specific to nondisplaceable binding ratios (SBR) values was found between iRBD and normal subjects at brainstem and thalamus levels while iRBD patients showed lower SBR values in all basal ganglia nuclei (P <0.0001) compared to controls. Conclusions: These results suggest that the serotonergic system is not directly involved in RBD pathogenesis while confirming nigro-striatal dopaminergic deafferentation in iRBD.",
keywords = "RBD, Serotonin, SPECT",
author = "Dario Arnaldi and Francesco Fam{\`a} and {De Carli}, Fabrizio and Silvia Morbelli and Michela Ferrara and Agnese Picco and Jennifer Accardo and Alberto Primavera and Gianmario Sambuceti and Flavio Nobili",
year = "2015",
month = "9",
day = "1",
doi = "10.5665/sleep.5000",
language = "English",
volume = "38",
pages = "1505--1509",
journal = "Sleep",
issn = "0161-8105",
publisher = "American Academy of Sleep Medicine",
number = "9",

}

TY - JOUR

T1 - The role of the serotonergic system in REM sleep behavior disorder

AU - Arnaldi, Dario

AU - Famà, Francesco

AU - De Carli, Fabrizio

AU - Morbelli, Silvia

AU - Ferrara, Michela

AU - Picco, Agnese

AU - Accardo, Jennifer

AU - Primavera, Alberto

AU - Sambuceti, Gianmario

AU - Nobili, Flavio

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Study Objectives: REM sleep behavior disorder (RBD) can be induced by antidepressants, especially serotonin reuptake inhibitors (SSRI), thus a role of the serotonergic system in the pathogenesis of RBD has been proposed. However, the serotonergic system integrity in idiopathic RBD (iRBD) is still unknown. We aimed to study brain stem serotonergic system integrity, by means of 123I-FP-CIT-SPECT, in a group of iRBD patients as compared to normal subjects. Design: Single-center, prospective observational study. Setting: University hospital. Patients or Participants: Twenty iRBD outpatients and 23 age-matched normal controls. Measurements and Results: The diagnosis of RBD was determined clinically and confirmed by means of overnight, laboratory-based videopolysomnography. Both iRBD patients and normal subjects underwent 123I-FP-CIT-SPECT as a marker of dopamine transporter (DAT) at basal ganglia level and of serotonin transporter (SERT) at brainstem and thalamus levels. 123I-FP-CIT-SPECT images were analyzed and compared between iRBD patients and controls by means of both region of interest analysis at basal ganglia, midbrain, pons and thalamus levels, and voxel-based analysis, taking into account age and the use of SSRI as confounding factors. No difference in 123I-FP-CIT-SPECT specific to nondisplaceable binding ratios (SBR) values was found between iRBD and normal subjects at brainstem and thalamus levels while iRBD patients showed lower SBR values in all basal ganglia nuclei (P <0.0001) compared to controls. Conclusions: These results suggest that the serotonergic system is not directly involved in RBD pathogenesis while confirming nigro-striatal dopaminergic deafferentation in iRBD.

AB - Study Objectives: REM sleep behavior disorder (RBD) can be induced by antidepressants, especially serotonin reuptake inhibitors (SSRI), thus a role of the serotonergic system in the pathogenesis of RBD has been proposed. However, the serotonergic system integrity in idiopathic RBD (iRBD) is still unknown. We aimed to study brain stem serotonergic system integrity, by means of 123I-FP-CIT-SPECT, in a group of iRBD patients as compared to normal subjects. Design: Single-center, prospective observational study. Setting: University hospital. Patients or Participants: Twenty iRBD outpatients and 23 age-matched normal controls. Measurements and Results: The diagnosis of RBD was determined clinically and confirmed by means of overnight, laboratory-based videopolysomnography. Both iRBD patients and normal subjects underwent 123I-FP-CIT-SPECT as a marker of dopamine transporter (DAT) at basal ganglia level and of serotonin transporter (SERT) at brainstem and thalamus levels. 123I-FP-CIT-SPECT images were analyzed and compared between iRBD patients and controls by means of both region of interest analysis at basal ganglia, midbrain, pons and thalamus levels, and voxel-based analysis, taking into account age and the use of SSRI as confounding factors. No difference in 123I-FP-CIT-SPECT specific to nondisplaceable binding ratios (SBR) values was found between iRBD and normal subjects at brainstem and thalamus levels while iRBD patients showed lower SBR values in all basal ganglia nuclei (P <0.0001) compared to controls. Conclusions: These results suggest that the serotonergic system is not directly involved in RBD pathogenesis while confirming nigro-striatal dopaminergic deafferentation in iRBD.

KW - RBD

KW - Serotonin

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=84940778031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940778031&partnerID=8YFLogxK

U2 - 10.5665/sleep.5000

DO - 10.5665/sleep.5000

M3 - Article

AN - SCOPUS:84940778031

VL - 38

SP - 1505

EP - 1509

JO - Sleep

JF - Sleep

SN - 0161-8105

IS - 9

ER -